Aspirin and the Medicine Cabinet, Part II

  • Steven M. RooneyEmail author
  • J. N. Campbell
Part of the SpringerBriefs in Molecular Science book series (BRIEFSMOLECULAR)


By the end of 1918, as the world reeled at the prospect of more death not at the end of a gun, but rather at the hands of the non-discriminating flu epidemic, Bayer’s former hold on the aspirin market was in a free-fall. Now firmly in the clutches of the Alien Property Custodian (APC), the German-based firm faced the prospect of being carved up piecemeal. The international division in the United States was up for public auction, and back home foreign investors were seeking to claim mysteriously open shares that were available through the inner workings of the Versailles Peace Treaty . For the time being, Carl Duisberg’s dream of a hegemonic empire of Bayer crosses was at an end.


Patent Medicine Advertising Budget Brand Identity Monocalcium Phosphate Medicine Cabinet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mann C, Plummer M (1991) The aspirin wars: money, medicine, and 100 years of rampant competition. Knopf, New YorkGoogle Scholar
  2. 2.
    Jeffreys D (2004) Aspirin: the remarkable story of a wonder drug. Bloomsbury, LondonGoogle Scholar
  3. 3.
    McTavish J (2004) Pain and profits: the history of the headache and its remedies in America. Rutgers University, New BrunswickGoogle Scholar
  4. 4.
    Jeffreys D (2010) Hell’s cartel: IG Farben and the making of Hitler’s war machine. Holt, New YorkGoogle Scholar
  5. 5.
    Weber K (2008) Cultures of order: leadership, language, and social reconstruction in Germany and Japan. State University of New York Press, New YorkGoogle Scholar
  6. 6.
    Cowan R (1994) Coal stoves and clean sinks: housework between 1890 and 1930. In: Foy J (ed) American home life, 1880–1930: a social history of spaces and services. University of Tennessee, KnoxvilleGoogle Scholar
  7. 7.
    Foy J (ed) (1995) The arts and the American home, 1890–1930. University of Tennessee Press, KnoxvilleGoogle Scholar
  8. 8.
    Sedivy J, Carlson G (2011) Sold on language: how advertisers talk to you and what that says about you. Wiley Publishing, West Sussex, UKGoogle Scholar
  9. 9.
    Strasser S (2000) Never done: a history of American housework. Henry Holt, New YorkGoogle Scholar
  10. 10.
    Culley S (2014) Killing pain? Aspirin, emotion and subjectivity. In: Boddice R (ed) Pain and emotion in modern history. Palgrave, LondonGoogle Scholar
  11. 11.
    Cohen L (2003) A consumers’ republic: the politics of mass consumption in postwar America. Vintage Books, New YorkGoogle Scholar
  12. 12.
    Painter NI (2013) Standing at armageddon: a grassroots history of the progressive era. W.W.Norton and Company, New YorkGoogle Scholar
  13. 13.
    Fox S (1984) The mirror makers: a history of American advertising and its creators. Morrow, New York, p 187, 190–191Google Scholar
  14. 14.
    Li J (2014) Blockbuster drugs: the rise and decline of the pharmaceutical industry. Oxford Press, Oxford, p 140Google Scholar
  15. 15.
    Schwarz M (2016). ADHD nation: children, doctors, big pharma, and the making of an America epidemic. Scribner, New York, p 173Google Scholar

Copyright information

© The Author(s) 2017

Authors and Affiliations

  1. 1.Independent ScholarIrvingUSA
  2. 2.Independent ScholarSpringUSA

Personalised recommendations